Gabrielle Alison Silver, Director at OPIANT PHARMACEUTICALS, INC. (OPNT), bought 2,500 shares at $13.29 ($33K) on 2022-05-16, disclosed to the SEC on 2022-05-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| OPNT | BUY | 2019-11-25 | $24K | — | Filing → |